Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a

subsidiary A subsidiary, subsidiary company or daughter company is a company owned or controlled by another company, which is called the parent company or holding company. Two or more subsidiaries that either belong to the same parent company or having a s ...

Eli Lilly and Company Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel ...

, before being divested. It is the third-largest animal health company in the world.

History

The company can trace its roots back to 1953 when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division led by George Barnes. In the 1960s, the Agro-Industrial division was reorganised launching Elanco Products, short for the parent company name, Eli Lilly and Company. The 1970s marked a decade of expansion for the business, increasing international operations to 38 global affiliates and 17 manufacturing locations. In the 1980s research moved away from plant sciences and focused on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focusing solely on animal health. In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International in order to address food security in developing nations. In 2009 the business launched its data analytics business, Elanco Knowledge Solutions. In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site. In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health and committed to ending hunger for 100,000 families through the Heifer International partnership. In 2012 the business acquired ChemGen Corp., improving their offering in enzyme-based nutrient absorption tools for food-livestock. In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum and

Novartis Animal Health Novartis AG is a Swiss-American multinational pharmaceutical corporation based in Basel, Switzerland and Cambridge, Massachusetts, United States (global research).name="novartis.com">https://www.novartis.com/research-development/research-loca ...

for $5.4 billion, the former boosting Elanco's poultry and vaccine business and the latter increasing a broad spectrum of treatments across companion animal, livestock, vaccine and aquaculture offerings. In 2016 Elanco expanded its US-based business, acquiring a suite of vaccines from Boehringer Ingelheim Vetmedica for $885 million. In 2013, Elanco made a $100M investment in China Animal Healthcare, a leading manufacturer of Animal pharmaceuticals in China. In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ''ELAN''. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year, the US FDA approved

rabacfosadine Rabacfosadine, sold under the brand name Tanovea-CA1, is a guanine nucleotide analog used for the treatment of lymphoma in dogs. The drug was granted conditional approval by the U.S. Food and Drug Administration under application number 141-475 ...

, a first-in-class treatment for canine lymphoma. The business continued to expand is US-business, acquiring Aratana Therapeutics, and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc. In the same year the business announced it would acquire Bayer's animal health business for $7.6 billion. On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021. In August 2021, Elanco announced it had closed its acquisition of Kindred Biosciences, enhancing its existing biologics and monoclonal antibody pipeline. Elanco's flea and tick collar, branded "Seresto" and manufactured by Bayer Animal Health which was acquired by Elanco in 2020, has been linked to more than 98,000 incidents of poisoning by pesticide, including more than 2,000 pet deaths, according to a 2022 report by a subcommittee of the House Committee on Oversight and Reform. The collars have been banned in Canada.

Acquisitions

*Elanco Products Company (Established 1954 as a division of Eli Lilly and Company) ** DowElanco (Established 1989 as joint venture with

Dow Chemical The Dow Chemical Company, officially Dow Inc., is an American multinational chemical corporation headquartered in Midland, Michigan, United States. The company is among the three largest chemical producers in the world. Dow manufactures plastics ...

, Sold stake 1999 to Dow) ***Ivy Animal Health (Acq 2007) ** Pfizer Animal Health (Acq 2010) ** Janssen Pharmaceutica Animal Health (Acq 2011) **ChemGen Corp (Acq 2012) **Lohmann SE (Acq 2014) ***Lohmann Animal Health (Acq 2014) **

(Acq 2014) ** Bayer Animal Health (Acq 2019) **Kindred Biosciences (Acq 2021)

References

External links

* {{authority control Veterinary medicine companies Pharmaceutical companies of the United States Health care companies based in Indiana Companies listed on the New York Stock Exchange 2018 initial public offerings Eli Lilly and Company Veterinary medicine in the United States Corporate spin-offs